Atlas Trials

Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax Malaria

Clinical trial NCT02110784 · TERMINATED

Trial details

NCT number
NCT02110784
Sponsor
Alfasigma S.p.A.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Malaria, Vivax
Start date
2014-06-18
Primary completion
2016-11-23
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.